Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153594 · ClinicalTrials.gov registry record · Phase 3
Early Re-Intervention Experiment 2
A Phase 3 study, sponsored by Chestnut Health Systems.
- Completed
- Registry status
- Phase 3
- Development phase
- 446
- Enrollment target
NCT01153594: Completed Phase 3 study, sponsored by Chestnut Health Systems.
NCT01153594 is a Phase 3 study that has completed, run by Chestnut Health Systems. The registered enrollment target is 446 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01153594, a Phase 3 study, has completed, sponsored by Chestnut Health Systems.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 446 participants
- Enrollment target
Study Summary
The objective of this study was to evaluate the relative effectiveness of quarterly Recovery Management Checkups (RMC) on long-term outcomes of adult chronic substance users over 4 years.
Primary Outcome
Days to readmission was calculated as the number of days from the date of the quarterly follow-up interview where the client first reported being in need of treatment (see below) to the date of the first subsequent intake to alcohol or other drug treatment following that interview.
Interventions
- BEHAVIORAL Recovery Management Checkups (RMC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2004-02 |
| Est. Completion | 2009-06 |
| Phase | Phase 3 |
What the finished NCT01153594 record still lists
NCT01153594 is an interventional study that assigns participants to a tested intervention. The registered 446 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 1 intervention - of which Recovery Management Checkups (RMC) is the first listed.
NCT01153594 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01153594 about?
NCT01153594 is a clinical study titled "Early Re-Intervention Experiment 2". The objective of this study was to evaluate the relative effectiveness of quarterly Recovery Management Checkups (RMC) on long-term outcomes of adult chronic substance users over 4 years.
What is the current status of trial NCT01153594?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 446 participants. The study started on 2004-02. Estimated completion is 2009-06.
What interventions are being tested in trial NCT01153594?
The interventions under investigation include: Recovery Management Checkups (RMC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01153594?
This trial is sponsored by Chestnut Health Systems, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01153594's enrollment target sits among peer trials
446 864th of 2000 higher than 1,137 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia